Look for Drugs and Conditions

ELETRIPTAN HBR

ELETRIPTAN HBR



Indications

Acute attack of migraine


Dosage

Adult 18-65 yr Initially 40 mg, repeated if necessary after 2 hr. Max: 160 mg/day.


Contra-Indications

Severe hepatic or renal impairment, uncontrolled HTN, confirmed CHD including ischaemic heart disease peripheral vascular disease. History of CVA or transient ischaemic attack. Concomitant ergotamine, ergotamine derivatives (including methysergide), other 5-HT1 receptor agonists.


Special Precautions

Not to be used in hemiplegic or basilar migraine.Elderly, renal impairement, pregnancy, lactation and children. Use in caution in drivers or machine operators.


Side Effects

Fatigue, somnolence, dizziness, nausea.


Drug Interactions

Erythromycin, ketoconazole, specific & potent CYP3A4 inhibitors eg itraconazole & clarithromycin.


Other Brands With Same Generic
Brand Name Manufactured by
ELIPRAN INTAS PHARMACEUTICALS LTD.
ELIPRAN INTAS PHARMACEUTICALS LTD.
RELPAX PFIZER LTD.
Ad 5